IR Roundtable Applications Close Today


Hi!

If your purview includes investor relations, I invite you to consider applying to join Year 2 of T2B’s IR Roundtable.

Apply here by midnight for one of three open spots on this roundtable.

What is the IR Roundtable?

Chaired by Deborah Elson, who heads up Corporate Communications and IR at Tonix Pharmaceuticals, this group brings biopharma communicators together to advance how IR and corporate communications work together to shape positioning and credibility.

In Year 2, the group will continue to build on discussions many of us are actively navigating:

  • How to integrate IR more effectively into broader corporate affairs strategy
  • How to communicate with investors and analysts in an increasingly volatile market
  • How to align IR planning with key milestones, including data readouts and ESG priorities

The roundtable will continue developing quarterly programming and practical resources for the T2B community, creating space for candid discussion and shared learning across IR-focused roles.

What’s the time commitment?

Members contribute ~3–5 hours per month, participate in working sessions, and co-create programming for the broader T2B community.

Who should apply?

We’re looking for T2B Pro members with experience in biopharma IR — in-house, agency, or consulting — who want to contribute actively and help shape how our industry approaches IR.

Looking forward to seeing who will help lead the next year of IR programming for our growing T2B communicator community!

Lynnea

T2B Monthly

Read more from T2B Monthly

Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...

Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out: Understand the economics of your clients' or...

Hi! Patient organizations are the closest link to the communities biopharma aims to serve. They see firsthand how messaging lands, including where it resonates, where it misses, and where it creates unintended friction. Our upcoming Patient Advocacy & Engagement Roundtable event brings together leaders across patient advocacy, healthcare communications, and patient-centered innovation to share how biopharma communications are experienced on the receiving end. What Patient Advocacy...